by Microbiologics | Oct 21, 2021 | Pharmaceutical
Growth Promotion Testing (GPT) is so foundational to Microbiological product safety that it can be easy to overlook. Most industrial microbiologists understand the importance of GPT, but this critical test is sometimes performed incompletely and inconsistently. A...
by Microbiologics | Sep 13, 2021 | Pharmaceutical
Burkholderia cepacia complex (Bcc) organisms are consistently a leading cause for microbiological recalls in the United States when contamination is identified. Requirements for Bcc testing were officially added to United States Pharmacopeia (USP) General Chapter...
by Microbiologics | Aug 3, 2021 | CRO, Pharmaceutical
When it comes to pre-clinical and clinical research in drug and therapy development, there are several areas of responsibility where sponsors may outsource key functions to a Contract Research Organization (CRO). The reasons vary, but the top two are cost...
by Andrea Marra | May 14, 2021 | Clinical, CRO, Molecular, Pharmaceutical
What if the latest tech device had all the bells and whistles everyone wanted and was far better than anything currently being sold, but the marketer was told he could not sell it until all the previous versions of his device had broken? And then, he had to sell his...
by Microbiologics | Feb 8, 2021 | Pharmaceutical
Since we launched our Custom Solutions program for environmental isolates and objectionable organisms in 2011, the most common strains have remained remarkably consistent. Even as the customers we serve (and the products they manufacture) have become increasingly...
by Microbiologics | Oct 23, 2020 | Pharmaceutical
As the use of cell lines to produce biopharmaceuticals continues to increase, Mycoplasma testing is a growing quality control challenge. Because of its unique properties, Mycoplasma poses many challenges for detection and management. Mycoplasma contamination can...
